{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:09:33Z","timestamp":1778875773998,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 20210"],"award-info":[{"award-number":["IG 20210"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-20176"],"award-info":[{"award-number":["IG-20176"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 20361"],"award-info":[{"award-number":["IG 20361"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014810","name":"Fondazione di Sardegna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.jcmgh.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T02:45:59Z","timestamp":1631587559000},"page":"113-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nrf2 Mutation\/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC"],"prefix":"10.1016","volume":"13","author":[{"given":"Sandra","family":"Mattu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Zavattari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta Anna","family":"Kowalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Sulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Puliga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Sutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Foglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Parola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Albano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Perra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6956-9030","authenticated-orcid":false,"given":"Amedeo","family":"Columbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2021.08.011_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","article-title":"Dual roles of Nrf2 in cancer","volume":"58","author":"Lau","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrc3278","article-title":"NRF2 and cancer: the good, the bad and the importance of context","volume":"12","author":"Sporn","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","article-title":"The dual roles of NRF2 in cancer","volume":"22","author":"Menegon","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2004.09.003","article-title":"Nrf2-Keap1 defines a physiologically important stress response mechanism","volume":"10","author":"Motohashi","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib6","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib9","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jso.21520","article-title":"Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer","volume":"101","author":"Takahashi","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-07-5003","article-title":"Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth","volume":"68","author":"Ohta","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib12","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-09-3352","article-title":"Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features","volume":"16","author":"Solis","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbrc.2007.08.051","article-title":"A\u00a0mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity","volume":"362","author":"Nioi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2559.2012.04178.x","article-title":"Somatic mutations of the KEAP1 gene in common solid cancers","volume":"60","author":"Yoo","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib15","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1158\/0008-5472.CAN-10-4668","article-title":"Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer","volume":"71","author":"Konstantinopoulos","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/hep.26540","article-title":"Identification of driver genes in hepatocellular carcinoma by exome sequencing","volume":"58","author":"Cleary","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cell.2019.07.031","article-title":"The oncogenic action of NRF2 depends on de-glycation by fructosamine-3-kinase","volume":"178","author":"Sanghvi","year":"2019","journal-title":"cell"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12885-015-1541-1","article-title":"Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.27790","article-title":"Nrf2, but not \u03b2-catenin, mutation represents an early event in rat hepatocarcinogenesis","volume":"62","author":"Zavattari","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2018.05.010","article-title":"Genetic inactivation of Nrf2 prevents clonal expansion of initiated cells in a nutritional model of rat hepatocarcinogenesis","volume":"69","author":"Orr\u00f9","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib22","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3390\/cancers12082305","article-title":"Distinct mechanisms are responsible for Nrf2-Keap1 pathway activation at different stages of rat hepatocarcinogenesis","volume":"12","author":"Orr\u00f9","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ccell.2016.04.006","article-title":"p62, Upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells","volume":"29","author":"Umemura","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jhbp.364","article-title":"Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma","volume":"23","author":"Shimizu","year":"2016","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/10715762.2020.1732955","article-title":"Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line","volume":"54","author":"Yasuda","year":"2020","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/hep4.1746","article-title":"Cooperation between the NRF2 pathway and oncogenic \u03b2-catenin during HCC tumorigenesis","volume":"5","author":"Savall","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31730","article-title":"Nrf2 and \u03b2-catenin coactivation in hepatocellular cancer: biological and therapeutic implications","volume":"74","author":"Tao","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib29","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.ajpath.2018.07.022","article-title":"High frequency of \u03b2-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist","volume":"188","author":"Mattu","year":"2018","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/toxsci\/kfy231","article-title":"Chemical activation of the constitutive androstane receptor leads to activation of oxidant-induced Nrf2","volume":"167","author":"Rooney","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib31","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.26616","article-title":"MicroRNA\/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC)","volume":"59","author":"Petrelli","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib35","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1158\/0008-5472.CAN-16-3538","article-title":"Nrf2 mutagenic activation drives hepatocarcinogenesis","volume":"77","author":"Ngo","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/cancers10120481","article-title":"Dysregulation of Nrf2 in hepatocellular carcinoma: role in cancer progression and chemoresistance","volume":"10","author":"Raghunath","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.dld.2012.10.008","article-title":"Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma","volume":"45","author":"De Minicis","year":"2013","journal-title":"Dig liver Dis"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib40","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/sj.onc.1208265","article-title":"B-Raf and Ha-ras mutations in chemically induced mouse liver tumors","volume":"24","author":"Jaworski","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib41","first-page":"66","article-title":"Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis","volume":"638","author":"Buchmann","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib42","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/sj.onc.1204982","article-title":"Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors","volume":"20","author":"Aydinlik","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib43","first-page":"333","article-title":"Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis","volume":"6","author":"Dragani","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mc.22510","article-title":"Role of the BrafV637E mutation in hepatocarcinogenesis induced by treatment with diethylnitrosamine in neonatal B6C3F1 mice","volume":"56","author":"Yamamoto","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cancers13010046","article-title":"The KEAP1-NRF2 system as a molecular target of cancer treatment","volume":"13","author":"Taguchi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib46","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ijc.28798","article-title":"Ha-ras and \u03b2-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors","volume":"135","author":"Unterberger","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2021.08.011_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X21001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:26:29Z","timestamp":1778873189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X21001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2352345X21001788"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.08.011","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 Mutation\/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}